5 results
424B5
SLNO
Soleno Therapeutics Inc
25 Oct 19
Prospectus supplement for primary offering
12:00am
:
(a) to legal entities which are authorized or regulated to operate in the financial markets or, if not so authorized or regulated, whose corporate … purpose is solely to invest in securities;
(b) to any legal entity which has two or more of (1) an average of at least 250 employees during the last
424B5
SLNO
Soleno Therapeutics Inc
22 Oct 19
Prospectus supplement for primary offering
4:24pm
are authorized or regulated to operate in the financial markets or, if not so authorized or regulated, whose corporate purpose is solely to invest
S-1/A
EX-10.5
SLNO
Soleno Therapeutics Inc
1 Jul 14
IPO registration (amended)
12:00am
received or held by it under the Plan for any corporate purpose, and the Company will not be obligated to segregate such Contributions except under
- Prev
- 1
- Next